Abbott Laboratories (ABT) Tops Q3 EPS by 1c; Narrows FY11 EPS Outlook
Tweet
Share
E-mailGet Alerts ABT Hot Sheet
Price: $106.71 -0.17%
EPS Growth %: -4.9%
Financial Fact:
Interest expense: 117M
Today's EPS Names:
FRSB, DGICA, UXIN, More
EPS Growth %: -4.9%
Financial Fact:
Interest expense: 117M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Abbott Laboratories (NYSE: ABT) reported Q3 EPS of $1.18, $0.01 better than the analyst estimate of $1.17. Revenue for the quarter came in at $9.82 billion versus the consensus estimate of $9.65 billion.
Abbott Laboratories sees FY2011 EPS of $4.64-$4.66, versus prior guidance of $4.58-$4.68 and the consensus of $4.64.
Abbott Laboratories sees FY2011 EPS of $4.64-$4.66, versus prior guidance of $4.58-$4.68 and the consensus of $4.64.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bristol-Myers Squibb (BMY) stock slips despite earnings beat
- Tractor Supply (TSCO) Tops Q1 EPS by 12c ; Offers Guidance
- First Resource Bank (FRSB) Tops Q1 EPS by 43c
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
